Scheme 3. Cerium(IV) Ammonium Nitrate (CAN)-mediated
Scheme 4. Hydrolysis of 2-Iminoindoline to Oxindole
Conversion of Indolines to Isatin Analog
should be noted that the isatin skeleton has been known to
have highly interesting bioactivities.12
Acknowledgment. This research was supported by the
KOSEF grant (No. R01-2007-000-10618-0) and CMDS at
KAIST. We acknowledge the Korea Basic Science Institute
(KBSI) for the mass analysis.
The synthetic utility of 2-sulfonyliminoindolines was
additionally demonstrated in the conversion of these mol-
ecules to oxindole derivatives. When indoline 3a was
hydrolyzed in acidic conditions, 1-methyloxindole (8) was
produced in good yield (Scheme 4). The oxindole species
are considered to be important building blocks in both
organic synthesis13 and medicinal chemistry.14 In fact, it is
known that oxindoles are readily derivatized into 2,3-
disubstituted indoles14 or 3-alkylideneoxindoles,15 which are
interesting metabolic intermediates.16
Supporting Information Available: Experimental details
1
and H and 13C NMR spectra of new compounds. This
material is available free of charge via the Internet at
OL800049B
In summary, we have developed a new synthetic route to
2-sulfonyliminoindolines using the reaction of 2-ethynyla-
nilines with sulfonyl azides in the presence of CuI catalyst.
Significantly, it offers important pharmacophores in good
yields with a wide substrate scope under mild reaction
conditions.
(14) (a) Mohanmmadi, M.; McMahon, G.; Sun, L.; Tang, C.; Hirth, P.;
Yeh, B. K.; Hubbard, S. R.; Schlessinger, J. Science 1997, 276, 955-960.
(b) Noble, M. E. M.; Endicott, J. A.; Johnson, L. N. Science 2004, 303,
1800-1805. (c) Yanada, R.; Obika, S.; Kobayashi, Y.; Inokuma, T.; Oyama,
M.; Yanada, K.; Takemoto, Y. AdV. Synth. Catal. 2005, 347, 1632-1642.
(15) (a) Deberly, A.; Abenhaim, D.; Bourdais, J. J. Heterocycl. Chem.
1975, 12, 1087-1090. (b) Bergman, J.; Carlsson, R.; Sjoberg, B. J.
Heterocycl. Chem. 1977, 14, 1123-1134.
(12) (a) Hyatt, J. L.; Moak, T.; Hatfield, M. J.; Tsurkan, L.; Edwards,
C. C.; Wierdl, M.; Danks, M. K.; Wadkins, R. M.; Potter, P. M. J. Med.
Chem. 2007, 50, 1876-1885. (b) Chu, W.; Rothfuss, J.; d’Avignon, A.;
Zeng, C.; Zhou, D.; Hotchkiss, R. S.; Mach, R. H. J. Med. Chem. 2007,
50, 3751-3755. (c) Vine, K. L.; Locke, J. M.; Ranson, M.; Pyne, S. G.;
Bremner, J. B. J. Med. Chem. 2007, 50, 5109-5117.
(13) (a) Inoue, M.; Furuyama, H.; Sakazaki, H.; Hirama, M. Org. Lett.
2001, 3, 2863-2865. (b) Kaiser, M.; Groll, M.; Renner, C.; Huber, R.;
Moroder, L. Angew. Chem., Int. Ed. 2002, 41, 780-783. (c) Albrecht, B.
K.; Williams, R. M. Org. Lett. 2003, 5, 197-200. (d) Lin, S.; Yang, Z-Q.
J. Am. Chem. Soc. 2004, 126, 6347-6355. (e) Miura, T.; Takshashi, Y.;
Murakami, M. Org. Lett. 2007, 9, 5075-5077.
(16) (a) Daisley, Roy W.; Walker, J. Eur. J. Med. Chem. 1979, 47-52.
(b) Bruni, P.; Cardellini, L.; Cardillo, B.; Tosi, G. J. Heterocycl. Chem.
1982, 19, 211-213. (c) Suresh, J. R.; Syam Kumar, U. K.; Ila, H.; Junjappa,
H. Tetrahedron 2001, 57, 781-790.
(17) (a) Tokunaga, T.; Hume, W. E.; Umezome, T.; Okazaki, K,; Ueki,
Y.; Kumagai, K.; Hourai, S.; Nagamine, J.; Seki, H.; Taiji, M.; Noguchi,
H.; Nagata, R. J. Med. Chem. 2001, 44, 4641-4649. (b) Ding, K.; Lu, Y.;
Nikolovska-Coleska, Z.; Wang, G.; Qiu, S.; Shangary, S.; Gao, W.; Qin,
D.; Stuckey, J.; Krajewski, K.; Roller, P. P.; Wang, S. J. Med. Chem. 2006,
49, 3432-3435. (c) Bindra, J.S. Oxindole Alkaloids. In Alkaloid Chemistry
and Physiology; Manske, R. H. F., Ed.; Academic Press: New York, 1973;
Vol. 14, pp 83-121.
1166
Org. Lett., Vol. 10, No. 6, 2008